ArticleLiver cancerPublished
Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Liver cancer
- Published
- Topic
- Clinical care
- Subject terms
- Neratinib; Fibrolamellar Carcinoma; Pan-her Kinase Inhibition; Summit Phase 2 Basket Study
- PubMed ID
- 40144471
- PubMed Central ID
- PMC11936434
- Open access
- Yes, open
- Added to directory
- Source checked